General Information
Version
DRE-C13201250 - Ergocristine
Revision date
2023-06-06
Product name
Ergocristine
Substance name
C ₃₅H₃₉N₅O₅ 609.71
Chemical name
Ergocristine
CAS No.
511-08-0
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC Limited
Emergency telephone
1-800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H311, H331, H361, H362
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Ergocristine
Signal word
Danger
Hazard statements
H301 - Toxic if swallowed H311 - Toxic in contact with skin H331 - Toxic if inhaled H361 - Suspected of damaging fertility or the unborn child H362 - May cause harm to breast-fed children
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapours/spray P263 - Avoid contact during pregnancy and while nursing P280 - Wear protective gloves/protective clothing/eye protection/face protection P301 + P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor P403 + P233 - Store in a well-ventilated place. Keep container tightly closed
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 3 - (H301) Acute toxicity - Dermal Category 3 - (H311) Acute toxicity - Inhalation (Dusts/Mists) Category 3 - (H331) Reproductive toxicity Category 2 - (H361) Effects on or via lactation Yes - (H362)
